BML Investment Partners, L.P. 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 4:44 pm Sale | 2026-05-11 | 13G | KEZAR LIFE SCIENCES INC KZR | BML Investment Partners, L.P. | 0 0.000% | -720,787 (Position Closed) | Filing |
| 2026-02-09 2:39 pm Purchase | 2025-12-31 | 13G | KEZAR LIFE SCIENCES INC KZR | BML Investment Partners, L.P. | 720,787 9.800% | 352,193 (+95.55%) | Filing |
| 2025-03-06 5:46 pm Purchase | 2025-02-28 | 13G | KEZAR LIFE SCIENCES INC KZR | BML Investment Partners, L.P. | 368,594 5.100% | 368,594 (New Position) | Filing |